Clinical Trial Update: Exenatide and Weight Loss for Diabetes Prevention [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating exenatide for weight loss in individuals with prediabetes and insulin resistance has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Prediabetes

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Stanford University | Conditions: Pre Diabetes, Insulin Resistance | Phase 1 | Status: COMPLETED